Prescription of transdermal nicotine patches for smoking cessation in general practice: evaluation of cost-effectiveness.

@article{Stapleton1999PrescriptionOT,
  title={Prescription of transdermal nicotine patches for smoking cessation in general practice: evaluation of cost-effectiveness.},
  author={John Andrew Stapleton and A V Lowin and Michael A. H. Russell},
  journal={Lancet},
  year={1999},
  volume={354 9174},
  pages={210-5}
}
BACKGROUND The 1998 UK government White Paper Smoking Kills emphasises that normal practice should be for general practitioners (GPs), practice nurses, and others to offer advice and support to smokers in their efforts to stop. However, GPs are not allowed to write NHS prescriptions for nicotine-replacement therapy, even though this is the only effective pharmaceutical treatment available in the UK. We estimated the cost-effectiveness, for the NHS, of allowing GPs to prescribe transdermal… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 38 extracted citations

Mathematical Modeling in Tobacco Control Research: Initial Results From a Systematic Review.

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco • 2016

One-year outcomes and a cost-effectiveness analysis for smokers accessing group-based and pharmacy-led cessation services.

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco • 2011

Pharmacogenetics of smoking cessation in general practice: results from the patch II and patch in practice trials.

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco • 2011

References

Publications referenced by this paper.

Prescription of transdermal nicotine patches for smoking cessation in general practice : evaluation of cost - effectiveness

A. RussellM
Lancet • 1999

Similar Papers

Loading similar papers…